Antidotes for factor Xa inhibitors and methods of using the same in combination with blood coagulating agents

Details for Australian Patent Application No. 2009314153 (hide)

Owner Portola Pharmaceuticals, Inc.

Inventors Lu, Genmin; Sinha, Uma

Agent Freehills

Pub. Number AU-A-2009314153

PCT Pub. Number WO2010/056765

Priority 61/114,948 14.11.08 US

Filing date 11 November 2009

Wipo publication date 20 May 2010

International Classifications

A61K 35/14 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution - Blood

A61K 38/48 (2006.01) Medicinal preparations containing peptides

A61P 7/04 (2006.01) Drugs for disorders of the blood or the extracellular fluid

Event Publications

26 May 2011 PCT application entered the National Phase

  PCT publication WO2010/056765 Priority application(s): WO2010/056765

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009314155-Thiochromene derivatives as HIF hydroxylase inhibitors

2009314147-Fibroblast growth factor-9 promotes hair follicle regeneration after wounding